Third Mayo Clinic and Karolinska Institutet Joint Cancer Research Symposium

Programme

8:00-8:05 CT / 3:00-3:05 CET- Welcome

Matthew P. Goetz, M.D. and Jonas Bergh, M.D.

8:05–8:20 CT / 3:05–3:20 CET- Introductory Remarks 

Cheryl L. Willman, M.D., Mayo Clinic Professor of Pathology and Medicine Executive Director, Mayo Clinic Cancer Programs Director, Mayo Clinic Cancer Center and Ole Petter Ottersen, M.D., Ph.D. Professor of Medicine President, Karolinska Institutet

8:20–8:50 CT / 3:20–3:50 CET- Novel NOTCH3-Based Therapies to Inhibit the Growth and Immune Evasion Capacity of Triple Negative Breast Cancer 

Tony D’Assoro, M.D., Ph.D. and Professor Urban Lendahl 2021 Mayo Clinic Cancer Center and Karolinska Institutet Breast Cancer Research Funding Awardees

8:50–9:20 CT / 3:50–4:20 CET - Exploration of fibroblasts as biologically relevant biomarkers in breast benign disease

Carina Strell Ph.D. on behalf of Derek Radisky, Ph.D. and Professor Arne Östman 2021 Mayo Clinic Cancer Center and Karolinska Institutet Breast Cancer Research Funding Awardees

9:20–9:40 CT / 4:20–4:40 CET- Break

9:40–10:05 CT / 4:40–5:05 CET - “Molecular insights into clonal hematopoiesis of indeterminate potential”

Mrinal Patnaik, M.B.B.S.

10:05–10:30 CT / 5:05–5:30 CET - "Surveillance and Targeting of Relapse-initiating MDS stem cells"

Professor Sten-Eirik Jacobsen M.D., Ph.D

10:30–10:55 CT / 5:30–5:55 CET- Spatial single-cell transcriptomics in triple-negative breast cancer: insights into the PD-(L)1 axis

Jodi M. Carter, M.D., Ph.D.

10:55–11:20 CT / 5:55–6:20 CET- "Mapping Tumor-Infiltrating Immune cells Using Spatial Transcriptomic"

Camilla Engblom Postdoctoral MSCA fellow

11:20–11:30 CT / 6:20–6:30 CET- Closing Remarks

Matthew P. Goetz, M.D. and Jonas Bergh, M.D.